COVID-19

Top news of the week from Pharmacy Times®.

Political insiders Donna L. Brazile and Michael Steele spoke to NASP members about which issues may concern them most and getting involved in the political process.

Although working from home created challenges for contacting stakeholders, some companies saw higher accuracy and fewer sick days among employees.

The keynote presentation will be broadcast virtually on 4 dates this fall and highlight cancer-specific guidance for pharmacists during the COVID-19 pandemic.

A study of Chinese women found COVID-19 heightened stress, fear, and depression during pregnancy.

Following the global impact of COVID-19 on the health care system in 2020, there have been some clear changes in HIV care in the United States.

The growth of telehealth, ongoing prescriber verification challenges, and the need for a universal patient identifier are all key issues that have arisen for pharmacists during the COVID-19 pandemic.

Students at the University of Illinois at Chicago College of Pharmacy answered the question “How has the pandemic impacted your summer internship/residency (or other pharmacy work)?”

In the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.

Although the presence of rhinovirus limited the ability of influenza to infect cells, researchers do not know whether the same effect will be seen with COVID-19.

In an interview with Pharmacy Times, National Community Pharmacists Association CEO B. Douglas Hoey, BSPharm, said he’s optimistic about having a vaccine for COVID-19 by the end of the year.

Pharmacy Times® interviewed Steven Lucio, vice president of Pharmacy Solutions at Vizient, on the ways that the COVID-19 pandemic has affected hospital spending this year, which is projected to result in increased drug spending for 2021.

The emergency use of drugs to shorten hospitalization and prolong time for COVID-19 vaccine research and development will serve as a critical temporary buffer for an efficient vaccine to combat SARS-CoV-2.

A new study published in JAMA suggests that prevention of both coronavirus disease 2019 (COVID-19) and seasonal influenza in US children is sensible and important for the well-being of the population.

Researchers at the Rensselaer Polytechnic Institute recently published a study on the use of the FDA-approved anticoagulant heparin in patients with COVID-19.

Top news of the week from Pharmacy Times®.

COVID-19 pandemic highlights how supplements can help improve the body’s defense system.

Contrary to earlier statements from the CDC, study suggests corticosteroid inhalers used by many asthmatics might make it more difficult for COVID-19 to enter the airways.

Promoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.

The pandemic is exacerbating many of the conditions that contribute to relapse or people using substances just to cope, including unemployment, stress, fear, anxiety, and isolation.

The results of the study found that adults who experienced 4 common symptoms of anxiety and depression have upwards of 2 times greater risk of delaying medical care or not receiving needed non-COVID-19 medical care amidst the pandemic.

The action is part of a growing movement to expand the ability of pharmacists and pharmacy staff to meet the needs of patients during the COVID-19 pandemic.

In a statement, CEO B. Douglas Hoey emphasized the important role pharmacists will play in distributing the vaccine once available.

Pharmacists can help manage medication-related problems to improve health outcomes during the pandemic.

Necessary measures taken during the pandemic may exacerbate some underlying factors that can lead to decline.